Chemours (NYSE:CC) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Chemours (NYSE:CC) posted its earnings results on Monday. The specialty chemicals company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.05), FiscalAI reports. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.53 billion. Chemours had a positive return on equity of 78.76% and a negative net margin of 2.64%. Chemours’s revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.40 EPS.

Chemours Stock Performance

Shares of CC stock traded up $0.63 during mid-day trading on Wednesday, hitting $13.72. The stock had a trading volume of 1,087,154 shares, compared to its average volume of 2,802,911. Chemours has a fifty-two week low of $10.44 and a fifty-two week high of $28.67. The firm has a market cap of $2.06 billion, a PE ratio of -13.42 and a beta of 1.47. The company has a debt-to-equity ratio of 18.98, a current ratio of 1.66 and a quick ratio of 0.88. The company’s 50-day simple moving average is $14.12 and its 200-day simple moving average is $18.25.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 16th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, November 16th. Chemours’s dividend payout ratio (DPR) is -18.32%.

Insider Transactions at Chemours

In other news, CEO Denise Dignam purchased 3,378 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average cost of $14.95 per share, with a total value of $50,501.10. Following the completion of the acquisition, the chief executive officer directly owned 339,916 shares of the company’s stock, valued at approximately $5,081,744.20. This trade represents a 1.00% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Shane Hostetter purchased 3,350 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The shares were purchased at an average cost of $14.94 per share, with a total value of $50,049.00. Following the completion of the acquisition, the chief financial officer directly owned 102,698 shares of the company’s stock, valued at $1,534,308.12. This represents a 3.37% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 8,663 shares of company stock worth $130,601 over the last ninety days. 0.85% of the stock is currently owned by company insiders.

Chemours News Roundup

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours launched FaizEon two-phase cooling fluids for AI and high-performance-computing data centers, targeting lower energy and water use as computing heat loads rise. The product could open a new growth opportunity, though its financial contribution is not yet established. Article: Chemours launches FaizEon cooling solutions
• Positive Sentiment: The company forecast fourth-quarter revenue of $1.7 billion–$1.8 billion, above the cited analyst consensus of $1.4 billion. Full-year revenue guidance of $5.9 billion was in line with consensus. Article: Chemours provides earnings guidance
• Neutral Sentiment: Goldman Sachs maintained a Hold rating with a $16 price target, citing strong Q3 results in some respects but weak volumes and a cautious near-term outlook. Article: Goldman Sachs maintains Hold rating
• Negative Sentiment: Q3 adjusted EPS was $0.21, below the $0.26 analyst estimate and down from $0.40 a year earlier. Revenue of $1.54 billion slightly exceeded estimates and rose 3% year over year, but the earnings miss and reported volume weakness weighed on the results. Article: Chemours reports third-quarter results
• Negative Sentiment: Multiple law firms are publicizing a filed securities class action covering investors who bought shares from February 20 to August 4, 2026. The allegations focus on statements about Opteon refrigerant aftermarket demand and distributor inventory; one notice says roughly $65 million in sales may have shifted from 2026 into 2025. The lead-plaintiff deadline is December 7. These reminders add legal and reputational risk, but are not separate new lawsuits. Article: Class-action reminder and allegations

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Truist Financial cut their price objective on Chemours from $24.00 to $20.00 and set a “buy” rating on the stock in a research report on Tuesday, October 20th. Morgan Stanley set a $18.00 price objective on shares of Chemours in a research note on Monday, August 10th. Barclays initiated coverage on shares of Chemours in a research report on Monday, October 12th. They set an “equal weight” rating and a $16.00 target price on the stock. BMO Capital Markets dropped their price target on Chemours from $26.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday, August 13th. Finally, Zacks Research raised Chemours from a “strong sell” rating to a “hold” rating in a research report on Thursday, September 10th. Three investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Chemours has an average rating of “Hold” and a consensus target price of $17.73.

Chemours Company Profile

The Chemours Company (NYSE: CC) is a global chemistry company that develops and manufactures performance chemicals and advanced materials for industrial and consumer applications. The company serves customers in markets including automotive, construction, energy, electronics, healthcare, and general manufacturing.

Chemours operates through businesses focused on Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Its products include titanium dioxide pigments used to provide whiteness and opacity in coatings, plastics, and paper; refrigerants and related thermal-management solutions; and high-performance fluoropolymers and specialty materials sold under brands such as Teflon™, Viton™, and Nafion™.

Headquartered in Wilmington, Delaware, Chemours serves customers globally through manufacturing facilities, research and development operations, and commercial activities across North America, Latin America, Europe, and Asia-Pacific.